A Food and Drug Administration panel recommended approval of a drug made of cannabidiol on April 19 to treat two
Why marijuana fans should not see approval for epilepsy drug as a win for weed
Interventions to decrease cardiovascular disease are not one-size-fits-all
In a recently published study in the Annals of Family Medicine, Aimee English, MD, et al, describe a cluster-randomized trial